Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro
Pathogens and Disease · 2023
DOI: 10.1093/femspd/ftad007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens and Disease, 2023. Verfasst von Mümtaz Güran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Faculty of Medicine, Eastern Mediterranean University, 99628 Famagusta, N. Cyprus via Mersin 10, Turkey. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Anti-Infective Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several studies have demonstrated that the effectiveness of carbapenems against drug-resistant Acinetobacter baumannii infections has been decreasing. Combination therapy with two or more drugs is currently under investigation to overcome the emerging resistance against carbapenems. In this study, we tested the possible synergistic interactions of a potent antibacterial flavonoid, baicalein, with meropenem to illustrate this duo’s antibacterial and antibiofilm effects on 15 extensively drug resistant or pan-drug-resistant (XDR/PDR) A. baumannii clinical isolates in vitro. Isolates included in the study were identified with MALDI-TOF MS, and antibiotic resistance patterns were studied according to EUCAST protocols. Carbapenem resistance was confirmed with the modified Hodge test, and resistance genes were also analyzed with genotypical methods. Then, checkerboard and time-kill assays were performed to analyze antibacterial synergism. Additionally, a biofilm inhibition assay was performed for screening the antibiofilm activity. To provide structural and mechanistic insights into baicalein action, protein–ligand docking, and interaction profiling calculations were conducted. Our study shed light on the remarkable potential of the baicalein–meropenem combination, since either synergistic or additive antibacterial activity was observed against every XDR/PDR A. baumannii strain in question. Furthermore, the baicalein–meropenem combination displayed significantly better antibiofilm activity in contrast to standalone use. In silico studies predicted that these positive effects arose from inhibition by baicalein of A. baumannii beta-lactamases and/or penicillin-binding proteins. Overall, our findings highlight the prospective potential benefits of baicalein in combination with meropenem for the treatment of carbapenem-resistant A. baumannii infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Faculty of Medicine, Eastern Mediterranean University, 99628 Famagusta, N. Cyprus via Mersin 10, Turkey.
- Department of Chemistry, Faculty of Arts and Sciences, Eastern Mediterranean University, 99628 Famagusta, N. Cyprus via Mersin 10, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Cyprus International University, 99258 N. Cyprus via Mersin 10, Turkey.
- Department of Medical Microbiology, Faculty of Medicine, Çukurova University, 1380 Adana, Turkey.
- Department of Biotechnology, Faculty of Science, The Campus of Çiftlikköy, Mersin University, 33343 Yenişehir, Mersin, Turkey.
ORCID-Profile: Mümtaz Güran, Kadir Çakıral, Kerem Teralı, Tülay Kandemir, Gizem Şanlıtürk, Melda Meral Öcal, Toğrul Nagiyev, Fatih Köksal
Zitieren
APA
Güran, M., Çakıral, K., Teralı, K., Kandemir, T., Şanlıtürk, G., Öcal, M. M., Nagiyev, T., & Köksal, F. (2023). Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Pathogens and Disease. https://doi.org/10.1093/femspd/ftad007
Vancouver
Güran M, Çakıral K, Teralı K, Kandemir T, Şanlıtürk G, Öcal MM, et al. Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Pathogens and Disease. 2023. doi:10.1093/femspd/ftad007
BibTeX
@article{Gran2023,
author = {Güran, Mümtaz and Çakıral, Kadir and Teralı, Kerem and Kandemir, Tülay and Şanlıtürk, Gizem and Öcal, Melda Meral and Nagiyev, Toğrul and Köksal, Fatih},
title = {Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro},
journal = {Pathogens and Disease},
year = {2023},
doi = {10.1093/femspd/ftad007}
}
EUVIMED